Ireland· IE-PA-PA25288/006/001
Prismasol 2 mmol/l Potassium solution for haemodialysis/haemofiltration
A hemofiltrates product containing glucose (as monohydrate) + magnesium chloride hexahydrate + calcium chloride dihydrate + lactic acid, registered in Ireland by Vantive Belgium SRL. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Glucose (as monohydrate) + magnesium chloride hexahydrate + calcium chloride dihydrate + lactic acid is registered in 11 of 19 countries.
Countries holding a registration under ATC B05ZB (hemofiltrates), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Glucose (as monohydrate) + magnesium chloride hexahydrate + calcium chloride dihydrate + lactic acid · ATC B05ZB
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Glucose (as monohydrate) + Magnesium chloride hexahydrate + Calcium chloride dihydrate + Lactic acid
- Manufacturer
- Vantive Belgium SRL
- Country
- Ireland (IE)
- ATC code
- B05ZB
- ATC class
- Hemofiltrates
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA25288/006/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glucose (as monohydrate) + magnesium chloride hexahydrate + calcium chloride dihydrate + lactic acid in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a67d498b-606a-4829-a530-ad42fd350a7b GET /v1/drugs/a67d498b-606a-4829-a530-ad42fd350a7b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for haemodialysis/haemofiltration",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"B05ZB"
],
"strength": null,
"pa_number": "PA25288/006/001",
"substances": [
"Glucose (as monohydrate)",
"Magnesium chloride hexahydrate",
"Calcium chloride dihydrate",
"Lactic acid",
"Sodium chloride",
"Potassium chloride",
"Sodium hydrogen carbonate",
"Calcium",
"Magnesium",
"Sodium",
"Lactate",
"Hydrogen carbonate",
"Chloride",
"Potassium",
"Glucose"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "12/12/2003",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about glucose (as monohydrate) + magnesium chloride hexahydrate + calcium chloride dihydrate + lactic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.